Affomix

New Haven, United States Founded: 2006 • Age: 20 yrs Acquired By Illumina
Human monoclonal antibodies are selected using proprietary high-throughput technology.
Request Access

About Affomix

Affomix is a company based in New Haven (United States) founded in 2006 was acquired by Illumina in July 2010.. Affomix has raised $7 million across 4 funding rounds from investors including Illumina, Four Seasons and HHS. Affomix operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.

  • Headquarter New Haven, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $7 M (USD)

    in 4 rounds

  • Latest Funding Round
    $111.35 K (USD), Grant

    May 05, 2008

  • Investors
    Illumina

    & 4 more

  • Employee Count
    Employee Count
  • Acquired by
    Illumina

    (Jul 01, 2010)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Affomix

Affomix has successfully raised a total of $7M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $111.35 thousand completed in May 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $111,350
  • First Round

    (24 Nov 2007)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2008 Amount Grant - Affomix Valuation

investors

HHS
Jan, 2008 Amount Series A - Affomix Valuation Connecticut Innovations , Elm Street Ventures
Dec, 2007 Amount Grant - Affomix Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Affomix

Affomix has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Illumina, Four Seasons and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
Founded Year Domain Location
VC firm investing in seed & early stage companies in the US
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Affomix

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Affomix

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Affomix Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Affomix

Affomix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
RNA-editing technologies are provided for precision medicine applications.
domain founded_year HQ Location
Dental implants and regenerative dentistry products are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Affomix

Frequently Asked Questions about Affomix

When was Affomix founded?

Affomix was founded in 2006 and raised its 1st funding round 1 year after it was founded.

Where is Affomix located?

Affomix is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.

Is Affomix a funded company?

Affomix is a funded company, having raised a total of $7M across 4 funding rounds to date. The company's 1st funding round was a Grant of $100K, raised on Nov 24, 2007.

What does Affomix do?

Affomix was founded in 2006 in New Haven, United States, within the biotechnology sector. Proprietary technology is employed for rapid, automated selection of human monoclonal antibodies. Commercialization efforts focus on monoclonal antibodies, microarrays, and libraries applied in research, drug discovery, diagnostics, and therapeutics. Emphasis is placed on measuring large numbers of proteins in biological samples with sensitivity and accuracy. Operations are centered in the United States.

Who are the top competitors of Affomix?

Affomix's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Who are Affomix's investors?

Affomix has 5 investors. Key investors include Illumina, Four Seasons, HHS, Elm Street Ventures, and Connecticut Innovations.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available